Cytarabine 25021-0223
Product NDC
25021-0223- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intrathecal, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA211938
Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cytarabine | 100 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (25021-223-20) / 20 mL in 1 VIAL